World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
76172
World Ranking
1965
National Ranking
1115

Merrick I. Ross publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Merrick I. Ross sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 602 publications — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Merrick I. Ross D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Merrick I. Ross sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 136 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Merrick I. Ross is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on the field of medicine, with a strong emphasis on oncology. The subfields associated with their work include oncology, molecular biology, immunology, pulmonary and respiratory medicine, and surgery.

The scientist's research spans several important topics in cancer and immunotherapy, including:

  • Cutaneous Melanoma Detection and Management
  • CAR-T Cell Therapy Research
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Melanoma and MAPK Pathways
  • Virus-Based Gene Therapy Research
  • Cancer Research and Treatments

Merrick I. Ross has contributed to multiple recent academic papers, including:

  • "Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response", 2021, Science
  • "Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma", 2023, New England Journal of Medicine
  • "NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021", 2021, Journal of the National Comprehensive Cancer Network
  • "Neoadjuvant relatlimab and nivolumab in resectable melanoma", 2022, Nature
  • "Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB-IVM1a melanoma: a randomized, open-label, phase 2 trial", 2021, Nature Medicine

Frequent co-authors in Merrick I. Ross's publications include:

  • Jeffrey E. Gershenwald
  • Jennifer A. Wargo
  • Michael A. Davies
  • Rodabe N. Amaria
  • Sarah B. Fisher

The journals where Merrick I. Ross most often publishes include:

  • Journal of Clinical Oncology
  • Annals of Surgical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Nature
  • Annals of Oncology

Best Publications

  • Final Version of 2009 AJCC Melanoma Staging and Classification

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

  • Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

    Charles M. Balch;Antonio C. Buzaid;Seng-Jaw Soong;Michael B. Atkins

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Charles M. Balch;Seng-Jaw Soong;Jeffrey E. Gershenwald;John F. Thompson

  • Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    Robert H.I. Andtbacka;Howard L. Kaufman;Frances Collichio;Thomas Amatruda

  • Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

    Jeffrey E. Gershenwald;Richard A. Scolyer;Kenneth R. Hess;Vernon K. Sondak

  • Clinical Course of Breast Cancer Patients With Complete Pathologic Primary Tumor and Axillary Lymph Node Response to Doxorubicin-Based Neoadjuvant Chemotherapy

    Henry M. Kuerer;Lisa A. Newman;Terry L. Smith;Fred C. Ames

  • Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.

    Jeffrey E. Gershenwald;William Thompson;Paul F. Mansfield;Jeffrey E. Lee

  • The orderly progression of melanoma nodal metastases.

    Douglas Reintgen;C. Cruse;Karen Wells;Claudia Berman

  • Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.

    Charles M. Balch;Seng Jaw Soong;Alfred A. Bartolucci;Marshall M. Urist

  • Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

    Jason Chesney;Igor Puzanov;Frances Collichio;Parminder Singh

  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

    Rodabe N. Amaria;Sangeetha M. Reddy;Hussein A. Tawbi;Michael A. Davies

  • Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma

    John Albertini;C. Cruse;David Rapaport;Karen Wells

  • Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Bianca D. Lemos;Barry E. Storer;Jayasri G. Iyer;Jerri Linn Phillips

  • Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

    Jeffrey E. Gershenwald;Maria I. Colome;Jeffrey E. Lee;Paul F. Mansfield

  • Long-Term Results of a Multi-Institutional Randomized Trial Comparing Prognostic Factors and Surgical Results for Intermediate Thickness Melanomas (1.0 to 4.0 mm)

    Charles M. Balch;Seng Jaw Soong;Merrick I. Ross;Marshall M. Urist

  • An Evidence‐based Staging System for Cutaneous Melanoma

    Charles M. Balch;Seng Jaw Soong;Michael B. Atkins;Antonio C. Buzaid

  • A new American Joint Committee on Cancer staging system for cutaneous melanoma.

    Charles M. Balch;Antonio C. Buzaid;Michael B. Atkins;Natale Cascinelli

  • Lymphedema beyond breast cancer

    Janice Nicole Cormier;Robert L. Askew;Kristi S. Mungovan;Yan Xing

  • Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases

    Charles M. Balch;Jeffrey E. Gershenwald;Seng Jaw Soong;John F. Thompson

Frequent Co-Authors

Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
Janice N. Cormier
Janice N. Cormier The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
S. Eva Singletary
S. Eva Singletary The University of Texas MD Anderson Cancer Center
Funda Meric-Bernstam
Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
Gildy Babiera
Gildy Babiera The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine in the USA, there are several related online degrees and pathways to expand your qualifications or enter the healthcare field. For nurses seeking advanced leadership roles, msn to dnp programs online offer a flexible way to obtain a Doctor of Nursing Practice degree.

If your interests lean towards pharmacology, pursuing pharmacy school online allows you to access advanced pharmacy education remotely, opening doors to both clinical and research roles.

For those passionate about healthcare technology and management, an online health information management degree provides expertise in managing patient data, electronic records, and medical systems.

Additionally, administrative careers in healthcare are accessible through online medical billing and coding courses, equipping you with the skills to handle billing, insurance claims, and regulatory compliance.

These programs deliver high-quality education with the convenience of online learning, helping you build essential skills and open diverse career opportunities in the growing healthcare sector.

Best Scientists Citing Merrick I. Ross

Trending Scientists

Recently Published Articles